Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans

Biochemical and Biophysical Research Communications

Volumn 364, Issue 1, 2007, Pages 157-162

  Kim, No Soo ^a   Kang, Kyungwon ^a   Cha, Min Ho ^a   Kang, Bong Joo ^a   Moon, Jinseok ^a   Kang, Byoung Kab ^a   Yu, Byeong Chan ^b   Kim, Yoon Sik ^b   Choi, Sun Mi ^a   Bang, Ok Sun ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b Daejeon University   (South Korea)

Author keywords

Blood lipids; Korean; PON1; Stroke

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; FEMALE; HUMAN; IN VIVO STUDY; KOREA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; STROKE PATIENT;

AGED; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL, HDL; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; RISK FACTORS; STROKE;

EID: 35349013067     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.09.119     Document Type: Article

References (32)

1. Hassett C., Richter R.J., Humbert R., Chapline C., Crabb J.W., Omiecinski C.J., and Furlong C.E. Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. Biochemistry 30 (1991) 10141-10149
2. Davies H.G., Richter R.J., Keifer M., Broomfield C.A., Sowalla J., and Furlong C.E. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet. 14 (1996) 334-336
3. Primo-Parmo S.L., Sorenson R.C., Teiber J., and La Du B.N. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33 (1996) 498-507
4. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Faull K.F., Fogelman A.M., and Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96 (1995) 2882-2891
5. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., and La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 101 (1998) 1581-1590
6. Mackness M.I., Arrol S., and Durrington P.N. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 286 (1991) 152-154
7. Leviev I., and James R.W. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 516-521
8. Shih D.M., Gu L., Xia Y.R., Navab M., Li W.F., Hama S., Castellani L.W., Furlong C.E., Costa L.G., Fogelman A.M., and Lusis A.J. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394 (1998) 284-287
9. Tward A., Xia Y.R., Wang X.P., Shi Y.S., Park C., Castellani L.W., Lusis A.J., and Shih D.M. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 106 (2002) 484-490
10. Kerkeni M., Addad F., Chauffert M., Chuniaud L., Miled A., Trivin F., and Maaroufi K. Hyperhomocysteinemia paraoxonase activity and risk of coronary artery disease. Clin. Biochem. 39 (2006) 821-825
11. Baum L., Ng H.K., Woo K.S., Tomlinson B., Rainer T.H., Chen X., Cheung W.S., Chan D.K., Thomas G.N., Tong C.S., and Wong K.S. Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk. Clin. Biochem. 39 (2006) 191-195
12. Ranade K., Kirchgessner T.G., Iakoubova O.A., Devlin J.J., DelMonte T., Vishnupad P., Hui L., Tsuchihashi Z., Sacks F.M., Sabatine M.S., Braunwald E., White T.J., Shaw P.M., and Dracopoli N.C. Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke. Stroke 36 (2005) 2346-2350
13. Hofer S.E., Bennetts B., Chan A.K., Holloway B., Karschimkus C., Jenkins A.J., Silink M., and Donaghue K.C. Association between PON 1 polymorphisms, PON activity and diabetes complications. J. Diabetes Complications 20 (2006) 322-328
14. Schmidt H., Schmidt R., Niederkorn K., Gradert A., Schumacher M., Watzinger N., Hartung H.P., and Kostner G.M. Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Stroke 29 (1998) 2043-2048
15. Huang Q., Liu Y.H., Yang Q.D., Xiao B., Ge L., Zhang N., Xia J., Zhang L., and Liu Z.J. Human serum paraoxonase gene polymorphisms, Q192R and L55M, are not associated with the risk of cerebral infarction in Chinese Han population. Neurol. Res. 28 (2006) 549-554
16. Pasdar A., Ross-Adams H., Cumming A., Cheung J., Whalley L., St Clair D., and MacLeod M.J. Paraoxonase gene polymorphisms and haplotype analysis in a stroke population. BMC Med. Genet. 7 (2006) 28
17. Hong S.H., Song J., Min W.K., and Kim J.Q. Genetic variations of the paraoxonase gene in patients with coronary artery disease. Clin. Biochem. 34 (2001) 475-481
18. +-ATPase activity. J. Physiol. Pharmacol. 53 (2002) 211-231
19. Kyrou I., Chrousos G.P., and Tsigos C. Stress, visceral obesity, and metabolic complications. Ann. N. Y. Acad. Sci. 1083 (2006) 77-110
20. Humphries S.E., and Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol. 3 (2004) 227-235
21. Navab M., Ananthramaiah G.M., Reddy S.T., Van Lenten B.J., Ansell B.J., Fonarow G.C., Vahabzadeh K., Hama S., Hough G., Kamranpour N., Berliner J.A., Lusis A.J., and Fogelman A.M. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J. Lipid Res. 45 (2004) 993-1007
22. Shaw P.X. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it. Arch. Immunol. Ther. Exp. (Warsz) 52 (2004) 225-239
23. Ansell B.J., Watson K.E., Fogelman A.M., Navab M., and Fonarow G.C. High-density lipoprotein function recent advances. J. Am. Coll. Cardiol. 46 (2005) 1792-1798
24. Voetsch B., Benke K.S., Damasceno B.P., Siqueira L.H., and Loscalzo J. Paraoxonase 192 Gln → Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults. Stroke 33 (2002) 1459-1464
25. Voetsch B., Benke K.S., Panhuysen C.I., Damasceno B.P., and Loscalzo J. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults. Arch. Neurol. 61 (2004) 351-356
26. James R.W., Leviev I., Ruiz J., Passa P., Froguel P., and Garin M.C. Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients. Diabetes 49 (2000) 1390-1393
27. Mackness B., Davies G.K., Turkie W., Lee E., Roberts D.H., Hill E., Roberts C., Durrington P.N., and Mackness M.I. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1451-1457
28. Sepahvand F., Shafiei M., Ghaffari S.M., Rahimi-Moghaddam P., and Mahmoudian M. Paraoxonase phenotype distribution in a healthy Iranian population. Basic Clin. Pharmacol. Toxicol. 101 (2007) 104-107
29. Schiavon R., Turazzini M., De Fanti E., Battaglia P., Targa L., Del Colle R., Fasolin A., Silvestri M., Biasioli S., and Guidi G. PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals. Acta Neurol. Scand. 116 (2007) 26-30
30. Beltowski J. Protein homocysteinylation: a new mechanism of atherogenesis?. Postepy Hig. Med. Dosw. (Online) 59 (2005) 392-404
31. Sumegova K., Blazicek P., Waczulikova I., Zitnanova I., and Durackova Z. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks. Acta Biochim. Pol. 53 (2006) 783-787
32. R. Turk, D. Juretić, D. Gereš, A. Svetina, N. Turk, Z. Flegar-Meštrić, Influence of oxidative stress and metabolic adaptation on PON1 activity and MDA level in transition dairy cows, Anim. Reprod. Sci. (2007) in press, doi:10.1016/j.anireprosci.2007.07.012.